MX394463B - Métodos para tratar trastornos del hígado o trastornos lipídicos con un agonista de thr-beta. - Google Patents
Métodos para tratar trastornos del hígado o trastornos lipídicos con un agonista de thr-beta.Info
- Publication number
- MX394463B MX394463B MX2019004492A MX2019004492A MX394463B MX 394463 B MX394463 B MX 394463B MX 2019004492 A MX2019004492 A MX 2019004492A MX 2019004492 A MX2019004492 A MX 2019004492A MX 394463 B MX394463 B MX 394463B
- Authority
- MX
- Mexico
- Prior art keywords
- disorders
- thr
- methods
- treating liver
- beta agonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662409833P | 2016-10-18 | 2016-10-18 | |
| US201762516594P | 2017-06-07 | 2017-06-07 | |
| PCT/US2017/057203 WO2018075650A1 (en) | 2016-10-18 | 2017-10-18 | Methods of treating liver disorders or lipid disorders with a thr-beta agonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019004492A MX2019004492A (es) | 2019-11-18 |
| MX394463B true MX394463B (es) | 2025-03-19 |
Family
ID=60480362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019004492A MX394463B (es) | 2016-10-18 | 2017-10-18 | Métodos para tratar trastornos del hígado o trastornos lipídicos con un agonista de thr-beta. |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11090308B2 (cg-RX-API-DMAC10.html) |
| EP (2) | EP3528817B1 (cg-RX-API-DMAC10.html) |
| JP (3) | JP2019533019A (cg-RX-API-DMAC10.html) |
| KR (2) | KR20230156159A (cg-RX-API-DMAC10.html) |
| CN (1) | CN110167557A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2017346871B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3040888A1 (cg-RX-API-DMAC10.html) |
| DK (1) | DK3528817T3 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2924257T3 (cg-RX-API-DMAC10.html) |
| IL (2) | IL302336B2 (cg-RX-API-DMAC10.html) |
| MX (1) | MX394463B (cg-RX-API-DMAC10.html) |
| WO (1) | WO2018075650A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2795450T3 (es) | 2012-09-17 | 2020-11-23 | Madrigal Pharmaceuticals Inc | Procedimiento para sintetizar análogos de hormonas tiroideas y polimorfos de los mismos |
| CA2968836C (en) | 2016-06-13 | 2025-09-02 | Gilead Sciences, Inc. | FXR MODULATING COMPOUNDS (NR1H4) |
| NZ748641A (en) | 2016-06-13 | 2020-04-24 | Gilead Sciences Inc | Fxr (nr1h4) modulating compounds |
| MX394463B (es) | 2016-10-18 | 2025-03-19 | Madrigal Pharmaceuticals Inc | Métodos para tratar trastornos del hígado o trastornos lipídicos con un agonista de thr-beta. |
| ES2982801T3 (es) | 2017-03-28 | 2024-10-17 | Gilead Sciences Inc | Combinaciones terapéuticas para el tratamiento de las enfermedades hepáticas |
| ES3029158T3 (en) * | 2018-06-12 | 2025-06-23 | Xizang Haisco Pharmaceutical Co Ltd | Thyroid hormone receptor agonists and uses thereof |
| US20210292304A1 (en) * | 2018-06-22 | 2021-09-23 | Hinova Pharmaceuticals Inc. | Deuterated mgl-3196 compound and use thereof |
| TW202615431A (zh) * | 2018-07-02 | 2026-04-16 | 美商瑪德瑞高製藥公司 | 2-(3,5-二氯-4-((5-異丙基-6-側氧基-1,6-二氫噠嗪-3-基)氧)苯基)-3,5-二側氧基-2,3,4,5-四氫-1,2,4-三嗪-6-腈之固體型式 |
| CA3111025C (en) | 2018-09-06 | 2023-10-31 | Galmed Research And Development Ltd | Combination therapy for the treatment of liver disease |
| TWI884745B (zh) | 2018-10-12 | 2025-05-21 | 美商拓臻股份有限公司 | 甲狀腺素受體β促效劑化合物 |
| CN121081472A (zh) | 2018-12-13 | 2025-12-09 | 拓臻股份有限公司 | 一种THRβ受体激动剂化合物及其制备方法和用途 |
| KR102692309B1 (ko) * | 2019-01-15 | 2024-08-07 | 길리애드 사이언시즈, 인코포레이티드 | Fxr (nr1h4) 조정 화합물 |
| WO2020172075A1 (en) | 2019-02-19 | 2020-08-27 | Gilead Sciences, Inc. | Solid forms of fxr agonists |
| CN119431265A (zh) | 2019-02-21 | 2025-02-14 | 南京瑞捷医药科技有限公司 | 一种作为甲状腺激素受体激动剂的化合物 |
| WO2020227549A1 (en) | 2019-05-08 | 2020-11-12 | Aligos Therapeutics, Inc. | MODULATORS OF THR-β AND METHODS OF USE THEREOF |
| CA3154488A1 (en) | 2019-08-23 | 2021-03-04 | Terns Pharmaceuticals, Inc. | Thyroid hormone receptor beta agonist compounds |
| CA3154391A1 (en) * | 2019-09-12 | 2021-03-18 | Terns Pharmaceuticals, Inc. | Thyroid hormone receptor beta agonist compounds |
| WO2021063367A1 (zh) * | 2019-09-30 | 2021-04-08 | 苏州科睿思制药有限公司 | 一种Resmetirom晶型及其制备方法和用途 |
| CA3158379A1 (en) * | 2019-11-26 | 2021-06-03 | Hejun Lv | 1,2,4-triazine-3,5-dione compound, preparation method therefor, and application thereof |
| CN111562321B (zh) * | 2020-04-16 | 2022-10-28 | 广东省结核病控制中心 | 用于检测活动性肺结核的粪便代谢物及其检测系统 |
| KR20230066408A (ko) * | 2020-09-10 | 2023-05-15 | 크리스탈 파마슈티컬 (쑤저우) 씨오., 엘티디. | 레스메티롬의 결정형, 이의 제조 방법 및 이의 용도 |
| US12616701B2 (en) | 2020-10-19 | 2026-05-05 | Assia Chemical Industries Ltd | Solid state forms of Resmetirom |
| WO2022165227A1 (en) * | 2021-02-01 | 2022-08-04 | Madrigal Pharmaceuticals, Inc. | Therapeutic combinations of rosuvastatin and resmetirom for the treatment of liver disorders or lipid disorders |
| US20250000836A1 (en) * | 2021-07-21 | 2025-01-02 | Cyta Therapeutics, Inc. | Particle delivery of thyroid hormone receptor agonists and antagonists |
| TW202337470A (zh) | 2021-09-27 | 2023-10-01 | 美商瑪德瑞高製藥公司 | 用於縮減肝臟體積之瑞美替隆 |
| MX2024005647A (es) * | 2021-11-11 | 2024-05-24 | Terns Pharmaceuticals Inc | Tratamiento de trastornos hepaticos con un agonista del thr-\03b2. |
| PE20252787A1 (es) | 2023-04-07 | 2025-12-22 | Terns Pharmaceuticals Inc | Combinacion que comprende un agonista de thr-beta y un agonista de glp-1r para su uso en el tratamiento de un trastorno hepatico o una enfermedad cardiometabolica |
| JP2026521649A (ja) * | 2023-06-22 | 2026-06-30 | マドリガル ファーマシューティカルズ インコーポレイテッド | THR-βアゴニストを用いて肝障害を治療するためのバイオマーカーおよび関連する使用 |
| WO2025011259A1 (zh) * | 2023-07-07 | 2025-01-16 | 苏州科睿思制药有限公司 | 瑞司美替罗的晶型及其制备方法和用途 |
| EP4762048A2 (en) | 2023-10-16 | 2026-06-24 | Cipla Limited | Resmetirom polymorphs and process for their preparation |
| US12377104B1 (en) | 2024-02-06 | 2025-08-05 | Madrigal Pharmaceuticals, Inc. | Methods for treating a fatty liver disease |
| WO2025245216A1 (en) * | 2024-05-22 | 2025-11-27 | Terns Pharmaceuticals, Inc. | Treatment of liver disorders with a thr-beta agonist |
| WO2026074443A1 (en) | 2024-10-01 | 2026-04-09 | Assia Chemical Industries Ltd. | Solid state forms of resmetirom |
| CN121648128B (zh) * | 2026-02-03 | 2026-06-30 | 华中科技大学同济医学院附属同济医院 | 特拉唑嗪或其药学上可接受的盐在制备用于预防和/或治疗肝纤维化的药物中的应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5615272A (en) | 1979-07-17 | 1981-02-14 | Ishihara Sangyo Kaisha Ltd | N-benzoyl-n'-phenylurea compound, its preparation, and insecticide containing the same |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| WO2004085406A1 (en) | 2003-03-24 | 2004-10-07 | F. Hoffmann-La Roche Ag | Benzyl-pyridazinons as reverse transcriptase inhibitors |
| ITRM20030363A1 (it) | 2003-07-24 | 2005-01-25 | Fernando Goglia | Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse. |
| US7807647B2 (en) | 2004-06-01 | 2010-10-05 | Pronai Therapeutics, Inc. | Methods and compositions for cancer therapy |
| US20050287667A1 (en) | 2004-06-01 | 2005-12-29 | Pronai Therapeutics, Inc. | Methods and compositions for the inhibition of gene expression |
| ATE480524T1 (de) | 2005-07-21 | 2010-09-15 | Hoffmann La Roche | Pyridazinonderivate als schilddrüsenhormon- rezeptoragonisten |
| ES2351274T3 (es) | 2007-06-06 | 2011-02-02 | Torrent Pharmaceuticals Ltd | Nuevos compuestos. |
| US8076334B2 (en) | 2007-09-20 | 2011-12-13 | Hoffmann-La Roche Inc. | Prodrugs of thyroid hormone analogs |
| ES2795450T3 (es) | 2012-09-17 | 2020-11-23 | Madrigal Pharmaceuticals Inc | Procedimiento para sintetizar análogos de hormonas tiroideas y polimorfos de los mismos |
| US8858502B2 (en) | 2012-10-10 | 2014-10-14 | Alcon Research, Ltd. | Systems and methods for external pressure sensing |
| WO2015123256A1 (en) * | 2014-02-14 | 2015-08-20 | Cempra Pharmaceuticals, Inc. | Compositions and methods for treating diabetes and liver diseases |
| MX394463B (es) | 2016-10-18 | 2025-03-19 | Madrigal Pharmaceuticals Inc | Métodos para tratar trastornos del hígado o trastornos lipídicos con un agonista de thr-beta. |
| TW202615431A (zh) | 2018-07-02 | 2026-04-16 | 美商瑪德瑞高製藥公司 | 2-(3,5-二氯-4-((5-異丙基-6-側氧基-1,6-二氫噠嗪-3-基)氧)苯基)-3,5-二側氧基-2,3,4,5-四氫-1,2,4-三嗪-6-腈之固體型式 |
-
2017
- 2017-10-18 MX MX2019004492A patent/MX394463B/es unknown
- 2017-10-18 WO PCT/US2017/057203 patent/WO2018075650A1/en not_active Ceased
- 2017-10-18 ES ES17804979T patent/ES2924257T3/es active Active
- 2017-10-18 EP EP17804979.7A patent/EP3528817B1/en active Active
- 2017-10-18 CN CN201780078133.2A patent/CN110167557A/zh active Pending
- 2017-10-18 KR KR1020237037485A patent/KR20230156159A/ko not_active Ceased
- 2017-10-18 AU AU2017346871A patent/AU2017346871B2/en active Active
- 2017-10-18 EP EP22175048.2A patent/EP4112056B1/en active Active
- 2017-10-18 KR KR1020197014495A patent/KR20190109387A/ko not_active Ceased
- 2017-10-18 IL IL302336A patent/IL302336B2/en unknown
- 2017-10-18 US US16/343,065 patent/US11090308B2/en active Active
- 2017-10-18 CA CA3040888A patent/CA3040888A1/en active Pending
- 2017-10-18 DK DK17804979.7T patent/DK3528817T3/da active
- 2017-10-18 JP JP2019542355A patent/JP2019533019A/ja active Pending
- 2017-10-18 IL IL266054A patent/IL266054B2/en unknown
-
2021
- 2021-07-07 US US17/369,197 patent/US11806353B2/en active Active
-
2023
- 2023-09-21 US US18/371,229 patent/US20240156826A1/en not_active Abandoned
- 2023-09-22 JP JP2023157999A patent/JP2024001055A/ja active Pending
-
2025
- 2025-05-12 JP JP2025079296A patent/JP2025122012A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017346871A1 (en) | 2019-05-02 |
| US20210330675A1 (en) | 2021-10-28 |
| EP3528817B1 (en) | 2022-05-25 |
| KR20190109387A (ko) | 2019-09-25 |
| US20240156826A1 (en) | 2024-05-16 |
| EP4112056A1 (en) | 2023-01-04 |
| IL266054A (en) | 2019-06-30 |
| ES2924257T3 (es) | 2022-10-05 |
| MX2019004492A (es) | 2019-11-18 |
| JP2024001055A (ja) | 2024-01-09 |
| EP4112056B1 (en) | 2026-01-21 |
| US11806353B2 (en) | 2023-11-07 |
| JP2019533019A (ja) | 2019-11-14 |
| WO2018075650A1 (en) | 2018-04-26 |
| US11090308B2 (en) | 2021-08-17 |
| EP3528817A1 (en) | 2019-08-28 |
| US20200230146A1 (en) | 2020-07-23 |
| CN110167557A (zh) | 2019-08-23 |
| JP2025122012A (ja) | 2025-08-20 |
| IL302336A (en) | 2023-06-01 |
| AU2017346871B2 (en) | 2023-08-03 |
| IL302336B2 (en) | 2025-11-01 |
| IL266054B1 (en) | 2023-06-01 |
| KR20230156159A (ko) | 2023-11-13 |
| DK3528817T3 (da) | 2022-08-08 |
| CA3040888A1 (en) | 2018-04-26 |
| IL266054B2 (en) | 2023-10-01 |
| IL302336B1 (en) | 2025-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019004492A (es) | Metodos para tratar trastornos del higado o trastornos lipidicos con un agonista de thr-beta. | |
| CY1125360T1 (el) | Αγωνιστες 5ητ για τη θεραπεια διαταραχων επιληψιας | |
| CL2020000938A1 (es) | Anticuerpos anti-tigit, sus composiciones y uso. (divisional solicitud 201800744) | |
| CR20170131A (es) | Anticuerpos anti-her2 e inmunoconjugados | |
| CL2018001556A1 (es) | Receptores de antígenos quiméricos (car) de bcma. (solicitud divisional 201701515) | |
| EP3429399A4 (en) | DRIVE MECHANISM FOR AUTOMATED SHOE PLATFORM | |
| ZA201807351B (en) | Novel gpr119 agonist compounds | |
| BR112016022345A2 (pt) | terapia de combinação compreendendo agentes antiangiogênese e agonistas de ligação de ox40 | |
| HUE069646T2 (hu) | Eljárások migrénes fejfájás kezelésére vagy megelõzésére CGRP receptor elleni antitestek alkalmazásával | |
| EP3437659A4 (en) | MEDICINE PRODUCED BY COMBINATION OF FXR AGONIST AND ARB | |
| MX2017001079A (es) | Receptores de antígeno quiméricos de antígeno de maduración de células b (bcma). | |
| EP4041722A4 (en) | GPR119 AGONISTS | |
| CR20150047A (es) | Anticuerpos anti-cd22 e inmunoconjugados | |
| EP3873478A4 (en) | METHOD OF IMPROVING IMMUNE-BASED THERAPY | |
| BR112018001853A2 (pt) | métodos para tratamento de um distúrbio e para melhoria do tratamento de um distúrbio | |
| BR112016026544A2 (pt) | métodos para inibir a necroptose | |
| PT3579826T (pt) | Métodos de tratamento de distúrbios de cdkl5 com o composto ov329 | |
| MX389448B (es) | Base de montaje para miembro de desgaste. | |
| IL283414A (en) | Methods of treating conditions related to the s1p1 receptor | |
| EP3482032A4 (en) | HORSESHOE SLIDING LIFT | |
| EP3385581A4 (en) | SHUT-OFF VALVE WITH PLATE REPLACEMENT STRUCTURE | |
| EP3443524A4 (en) | INFORM OPT-IN PREVIEWS FOR VIDEO ADVERTISING | |
| EP3639079A4 (en) | PROCESS RECORDING OBJECT CARRIERS FOR IMMUNHISTOCHEMICAL STAINING | |
| FR3057578B1 (fr) | Procede d'hydrodesulfuration d'une essence olefinique. | |
| CL2019003431S1 (es) | Máquina para bebidas. |